Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Pneumococcal Vaccine Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Pneumococcal Vaccine Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 PPSV 23
1.3.3 PCV 7/13
1.3.4 PCV 10
1.4 Market Segment by Application
1.4.1 Global Pneumococcal Vaccine Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Child
1.4.3 Adult
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Pneumococcal Vaccine Revenue (2015-2026)
2.1.1 Global Pneumococcal Vaccine Revenue (2015-2026)
2.1.2 Global Pneumococcal Vaccine Sales (2015-2026)
2.2 Pneumococcal Vaccine Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Pneumococcal Vaccine Sales by Regions (2015-2020)
2.2.2 Global Pneumococcal Vaccine Revenue by Regions (2015-2020)
2.3 Global Top Pneumococcal Vaccine Regions (Countries) Ranking by Market Size
2.4 Pneumococcal Vaccine Industry Trends
2.4.1 Pneumococcal Vaccine Market Top Trends
2.4.2 Market Drivers
2.4.3 Pneumococcal Vaccine Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Pneumococcal Vaccine Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Pneumococcal Vaccine Manufacturers by Sales (2015-2020)
3.1.1 Global Pneumococcal Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Pneumococcal Vaccine Sales in 2019
3.2 Global Top Manufacturers Pneumococcal Vaccine by Revenue
3.2.1 Global Pneumococcal Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Pneumococcal Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pneumococcal Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccine as of 2019)
3.4 Global Pneumococcal Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Pneumococcal Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Pneumococcal Vaccine Market
3.7 Key Manufacturers Pneumococcal Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pneumococcal Vaccine Historic Market Review by Type (2015-2020)
4.1.2 Global Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
4.1.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2015-2020)
4.1.4 Pneumococcal Vaccine Price by Type (2015-2020)
4.1 Global Pneumococcal Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Pneumococcal Vaccine Sales Forecast by Type (2021-2026)
4.2.3 Global Pneumococcal Vaccine Revenue Forecast by Type (2021-2026)
4.2.4 Pneumococcal Vaccine Price Forecast by Type (2021-2026)
5 Global Pneumococcal Vaccine Market Size by Application
5.1 Global Pneumococcal Vaccine Historic Market Review by Application (2015-2020)
5.1.2 Global Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
5.1.3 Global Pneumococcal Vaccine Revenue Market Share by Application (2015-2020)
5.1.4 Pneumococcal Vaccine Price by Application (2015-2020)
5.2 Global Pneumococcal Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Pneumococcal Vaccine Sales Forecast by Application (2021-2026)
5.2.3 Global Pneumococcal Vaccine Revenue Forecast by Application (2021-2026)
5.2.4 Pneumococcal Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pneumococcal Vaccine Breakdown Data by Company
6.2 North America Pneumococcal Vaccine Breakdown Data by Type
6.3 North America Pneumococcal Vaccine Breakdown Data by Application
6.4 North America Pneumococcal Vaccine Breakdown Data by Countries
6.4.1 North America Pneumococcal Vaccine Sales by Countries
6.4.2 North America Pneumococcal Vaccine Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pneumococcal Vaccine Breakdown Data by Company
7.2 Europe Pneumococcal Vaccine Breakdown Data by Type
7.3 Europe Pneumococcal Vaccine Breakdown Data by Application
7.4 Europe Pneumococcal Vaccine Breakdown Data by Countries
7.4.1 Europe Pneumococcal Vaccine Sales by Countries
7.4.2 Europe Pneumococcal Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pneumococcal Vaccine Breakdown Data by Company
8.2 Asia Pacific Pneumococcal Vaccine Breakdown Data by Type
8.3 Asia Pacific Pneumococcal Vaccine Breakdown Data by Application
8.4 Asia Pacific Pneumococcal Vaccine Breakdown Data by Regions
8.4.1 Asia Pacific Pneumococcal Vaccine Sales by Regions
8.4.2 Asia Pacific Pneumococcal Vaccine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Pneumococcal Vaccine Breakdown Data by Company
9.2 Latin America Pneumococcal Vaccine Breakdown Data by Type
9.3 Latin America Pneumococcal Vaccine Breakdown Data by Application
9.4 Latin America Pneumococcal Vaccine Breakdown Data by Countries
9.4.1 Latin America Pneumococcal Vaccine Sales by Countries
9.4.2 Latin America Pneumococcal Vaccine Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Vaccine Breakdown Data by Type
10.2 Middle East and Africa Pneumococcal Vaccine Breakdown Data by Application
10.3 Middle East and Africa Pneumococcal Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa Pneumococcal Vaccine Sales by Countries
10.3.2 Middle East and Africa Pneumococcal Vaccine Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Pfizer Pneumococcal Vaccine Products and Services
11.1.5 Pfizer SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Business Overview and Total Revenue (2019 VS 2018)
11.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 GSK Pneumococcal Vaccine Products and Services
11.2.5 GSK SWOT Analysis
11.2.6 GSK Recent Developments
11.3 MSD
11.3.1 MSD Corporation Information
11.3.2 MSD Business Overview and Total Revenue (2019 VS 2018)
11.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 MSD Pneumococcal Vaccine Products and Services
11.3.5 MSD SWOT Analysis
11.3.6 MSD Recent Developments
11.4 Sanofipasteur
11.4.1 Sanofipasteur Corporation Information
11.4.2 Sanofipasteur Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Sanofipasteur Pneumococcal Vaccine Products and Services
11.4.5 Sanofipasteur SWOT Analysis
11.4.6 Sanofipasteur Recent Developments
11.5 CDIBP
11.5.1 CDIBP Corporation Information
11.5.2 CDIBP Business Overview and Total Revenue (2019 VS 2018)
11.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 CDIBP Pneumococcal Vaccine Products and Services
11.5.5 CDIBP SWOT Analysis
11.5.6 CDIBP Recent Developments
12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Pneumococcal Vaccine Sales Channels
12.2.2 Pneumococcal Vaccine Distributors
12.3 Pneumococcal Vaccine Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Pneumococcal Vaccine Sales Forecast (2021-2026)
13.1.1 Global Pneumococcal Vaccine Sales Forecast by Regions (2021-2026)
13.1.2 Global Pneumococcal Vaccine Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Pneumococcal Vaccine Sales Forecast (2021-2026)
13.2.2 North America Pneumococcal Vaccine Revenue Forecast (2021-2026)
13.2.3 North America Pneumococcal Vaccine Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Pneumococcal Vaccine Sales Forecast (2021-2026)
13.3.2 Europe Pneumococcal Vaccine Revenue Forecast (2021-2026)
13.3.3 Europe Pneumococcal Vaccine Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Pneumococcal Vaccine Sales Forecast (2021-2026)
13.4.2 Asia Pacific Pneumococcal Vaccine Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Pneumococcal Vaccine Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Pneumococcal Vaccine Sales Forecast (2021-2026)
13.5.2 Latin America Pneumococcal Vaccine Revenue Forecast (2021-2026)
13.5.3 Latin America Pneumococcal Vaccine Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Pneumococcal Vaccine Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Pneumococcal Vaccine Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Pneumococcal Vaccine Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Pfizer、GSK、MSD、Sanofipasteur、CDIBP
【免責事項】
https://www.globalresearch.jp/disclaimer